MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Pathology & Lab Medicine

Section

Pathology & Lab Medicine

112 articles

Ask AI
All specialtiesPathology & Lab MedicinenewsClinical UpdatesCardiologyOncology

Latest updates

Cardiology

HEARTBiT: A Breakthrough Transcriptomic Biomarker for Early Detection of Acute Cellular Rejection Post-Heart Transplantation

HEARTBiT, a novel transcriptomic biomarker, effectively detects moderate-to-severe acute cellular rejection within the first year after heart transplantation, offering a minimally invasive alternative to biopsy, especially during the high-r

Oct 4, 2026Sign in to read
news

Discordance Between Gastric HER2 Scoring in Endometrial Sampling Versus Hysterectomy Specimens: Clinical Implications in High-Grade Endometrial Cancer

This study reveals significant discordance between HER2 scores from endometrial biopsy samples and hysterectomy specimens using gastric scoring criteria, impacting treatment decisions in high-grade endometrial cancer.

Sep 29, 2026
news

Unlocking the Diagnostic Potential of Peritoneal Fluid Small Extracellular Vesicle Proteins in Endometriosis

Peritoneal fluid-derived small extracellular vesicles exhibit distinct proteomic profiles in endometriosis, identifying potential biomarkers for improved diagnosis independent of cycle phase or disease stage.

Sep 29, 2026Sign in to read
Diabetes & Endocrinology

Harnessing Long-Read Sequencing to Revolutionize Diagnosis and Equity in Differences of Sex Development (DSD)

Long-read sequencing (LRS) improves genetic diagnosis of Congenital Adrenal Hyperplasia and other DSDs by resolving complex genomic variants, tightening phenotype-genotype correlations, and closing equity gaps in clinical care.

Sep 26, 2026
Hematology-Oncology

Enhancing Bone Marrow Fibrosis Diagnosis: Clinical Evaluation of AI-Driven Continuous Indexing of Fibrosis (CIF)

This study clinically validates an AI-based quantitative tool, CIF, for bone marrow fibrosis assessment, demonstrating improved reproducibility and accuracy over manual grading without increasing assessment time.

Sep 22, 2026Sign in to read
Diabetes & Endocrinology

Histological Subtypes of Pituitary Adenomas: Their Role in Acromegaly Surgical Outcomes and Disease Control

This study evaluates how different pituitary adenoma histological subtypes influence remission and disease control in acromegaly post-surgery, finding no significant differences though sparsely granulated adenomas show a trend toward lower

Sep 21, 2026
Diabetes & Endocrinology

New Consensus on Testosterone Reference Ranges for Females and Children: Outcomes of the 2024 PCOS Challenge–CDC Stakeholder Meeting

A stakeholder consensus sets a roadmap to develop standardized, age- and sex-specific testosterone reference intervals for women, adolescent girls, and children to improve diagnosis and care for androgen-related disorders.

Sep 19, 2026
news

Evaluating the Utility of Routine Tonsil Pathology in a Safety-Net Hospital: Low Yield of Unexpected Malignancies Supports Risk-Stratified Approach

A retrospective cohort study at a safety-net hospital found that routine pathological examination of tonsillectomy specimens rarely reveals unexpected malignancies, supporting targeted pathology based on clinical assessment.

Sep 18, 2026Sign in to read
news

Advancing Fetal Death Detection: Identification of Novel Maternal Plasma Biomarkers Through Large-Scale Proteomic Profiling

Large-scale proteomic analysis identifies novel maternal plasma protein biomarkers that improve detection of fetal death beyond established markers, highlighting both shared and unique pathological pathways with preeclampsia.

Sep 11, 2026Sign in to read
Diabetes & Endocrinology

Refining Risk Stratification in Indeterminate Thyroid Nodules: The Role of Afirma Xpression Atlas Alteration Status

Detection of genomic alterations via Afirma Xpression Atlas in indeterminate thyroid nodules enhances malignancy risk stratification beyond Afirma GSC results, guiding surgical decision-making.

Aug 30, 2026
Hematology-Oncology

Enhancing Prognostic Accuracy in Acute Myeloid Leukemia through DNA Methylation Signatures

DNA methylation profiling in AML patients reveals epigenetic subtypes that mirror genetic mutations, improving risk stratification and outcome prediction beyond standard genetic markers.

Aug 28, 2026
news

Enhancing Diagnostic Accuracy of Sinonasal Lesions: The Role of Narrow Band Imaging in Differentiating Inverted Papillomas from Nasal Polyps

Narrow-band imaging (NBI) significantly improves the endoscopic differentiation of inverted papillomas (IPs) from nasal polyps (NPs) by highlighting mucosal microvasculature patterns, achieving superior diagnostic accuracy compared to white

Aug 24, 2026
news

Early Prenatal Screening Revolution: Fetal Fraction Amplification Enables Reliable cfDNA Testing From 7 Weeks of Gestation

This study demonstrates that fetal fraction amplification significantly improves cell-free DNA screening feasibility as early as 7 3/7 weeks gestation, maintaining high accuracy and low failure rates, potentially transforming early prenatal

Aug 18, 2026
news

Advancing Early Triple Negative Breast Cancer Care: Tissue-Free Circulating Tumor DNA Assays for Molecular Residual Disease Detection

A recent study comparing tissue-free and tumor-informed ctDNA assays in early triple negative breast cancer reveals comparable accuracy and earlier detection of molecular residual disease, supporting tissue-free approaches for routine clini

Aug 16, 2026
Hematology-Oncology

ELN‑DAVID technical recommendations: NGS-based FLT3‑ITD MRD testing in AML — what clinicians and labs need to know

The ELN‑DAVID 2026 technical note establishes standards for NGS-based detection of FLT3‑ITD measurable residual disease (MRD) in AML, with lab validation, reporting, timing, and clinical-use recommendations to make FLT3‑ITD MRD testing acti

Aug 15, 2026
Diabetes & Endocrinology

Enzymatic 2-Hydroxybutyrate Assay: A Novel Screening Tool to Detect Dysglycemia Beyond Standard Fasting Tests

A novel enzymatic assay measuring fasting 2-hydroxybutyrate shows high accuracy in identifying postprandial dysglycemia in individuals with normal fasting glucose and HbA1c, offering an improved screening approach for early glucose metaboli

Aug 13, 2026
Hematology-Oncology

Decoding the Tumor Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic Insights from CD163 and CD11c Profiling

This study identifies distinct tumor immune microenvironment subgroups in diffuse large B-cell lymphoma based on CD163 and CD11c expression, revealing prognostic significance and potential therapeutic stratification with checkpoint inhibito

Aug 11, 2026
Hematology-Oncology

Decoding PIEZO1 Variants: Precision Insights into Hereditary Red Blood Cell and Iron Disorders

This study refines the classification of PIEZO1 variants using integrative genomic and phenotypic data, enhancing diagnosis and personalized management of hereditary red blood cell and iron disorders like dehydrated hereditary stomatocytosi

Jul 12, 2026
Infectious Diseases

Point-of-Care Multiplex PCR Testing in Nursing Homes: Impact on Respiratory Outbreak Management and Emergency Transfers

A cluster randomized trial in Toronto nursing homes found that on-site multiplex PCR testing improved viral detection and reduced emergency department transfers during respiratory outbreaks, though it did not alter outbreak size or frequenc

Jul 9, 2026
Clinical Updates

Circulating Methylated SEPT9 as a Novel Biomarker for Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients

Combining circulating methylated SEPT9 with alpha-fetoprotein significantly enhances early hepatocellular carcinoma detection in cirrhotic patients, outperforming AFP alone and allowing improved surveillance sensitivity and specificity.

Jul 7, 2026
Previous
2 / 6
1234…6
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.